Massachusetts Financial Services Co. MA Lowers Position in Encompass Health Corporation $EHC

Massachusetts Financial Services Co. MA trimmed its stake in Encompass Health Corporation (NYSE:EHC) by 14.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 136,099 shares of the company’s stock after selling 23,691 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Encompass Health were worth $14,446,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. Alliancebernstein L.P. grew its holdings in Encompass Health by 23.4% in the third quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock valued at $319,567,000 after purchasing an additional 476,564 shares during the period. Dimensional Fund Advisors LP grew its holdings in Encompass Health by 0.5% in the third quarter. Dimensional Fund Advisors LP now owns 1,616,178 shares of the company’s stock valued at $205,279,000 after purchasing an additional 7,349 shares during the period. Raymond James Financial Inc. grew its holdings in Encompass Health by 34.8% in the third quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock valued at $195,780,000 after purchasing an additional 397,694 shares during the period. JPMorgan Chase & Co. grew its position in Encompass Health by 5.3% during the third quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company’s stock valued at $179,141,000 after acquiring an additional 70,387 shares during the period. Finally, Millennium Management LLC grew its position in Encompass Health by 140.0% during the third quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock valued at $155,430,000 after acquiring an additional 713,738 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Encompass Health

In related news, CEO Mark J. Tarr sold 150,000 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total value of $16,746,000.00. Following the completion of the transaction, the chief executive officer owned 377,070 shares of the company’s stock, valued at approximately $42,096,094.80. This represents a 28.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Treasurer Edmund Fay sold 11,937 shares of the stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the transaction, the treasurer directly owned 89,325 shares of the company’s stock, valued at $9,557,775. This represents a 11.79% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the subject of a number of research reports. Barclays boosted their price target on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research report on Friday, February 6th. Wall Street Zen downgraded Encompass Health from a “buy” rating to a “hold” rating in a research report on Saturday, April 11th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $143.29.

Encompass Health Trading Up 0.2%

Shares of EHC opened at $105.47 on Friday. The company has a market capitalization of $10.49 billion, a P/E ratio of 19.04, a P/E/G ratio of 2.02 and a beta of 0.75. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 1.08. The stock has a 50-day moving average price of $104.35 and a 200 day moving average price of $109.15.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, February 5th. The company reported $1.46 EPS for the quarter, beating analysts’ consensus estimates of $1.29 by $0.17. The firm had revenue of $3.09 billion during the quarter, compared to the consensus estimate of $1.54 billion. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.Encompass Health’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.17 earnings per share. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Sell-side analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st were issued a $0.19 dividend. The ex-dividend date of this dividend was Wednesday, April 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s dividend payout ratio is currently 13.72%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.